<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04187430</url>
  </required_header>
  <id_info>
    <org_study_id>MICRO.HGUGM.2019-016</org_study_id>
    <nct_id>NCT04187430</nct_id>
  </id_info>
  <brief_title>Validation of a Prediction Score for Recurrent C. Difficile Infection: Implementation for Treatment Algorithm Strategies</brief_title>
  <acronym>Clostri_Score</acronym>
  <official_title>Validation of a Prediction Score for Recurrent C. Difficile Infection: Implementation for Treatment Algorithm Strategies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emilio Bouza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Elena Reigadas Ramirez</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Patricia Muñoz García</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital General Universitario Gregorio Marañon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the present study is to derive a high-risk R-ICD prediction rule and a
      prospective implementation of this prediction rule.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For objectives 1 and 2, a retrospective study of the microbiology database will be carried
      out and the medical records will be consulted to collect the variables included in Annex 2.
      The other prediction rules to be compared are those of Cobo et al., Reigadas et al and
      Gerding et al.

      We will review a total of 215 patients according to the calculation of the sample size (see
      section) A prospective study will also be carried out in which the positive patients for C.
      difficile determined by the Microbiology Service of the General University Hospital Gregorio
      Marañón will be included. The medical records of the selected cases will be reviewed. All
      patients included in the prospective study (Objective 3) will receive the information sheet
      and consent sheet that they must sign for this study (Annex 1). These patients will be
      followed and the variables included in Annex 2 will be collected.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Create Score</measure>
    <time_frame>31 december 2020</time_frame>
    <description>Create a high risk of recurrence score by reviewing a retrospective cohort of patients with DCI.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">513</enrollment>
  <condition>Clostridium Difficile Infection</condition>
  <arm_group>
    <arm_group_label>Retrospective group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Prospective group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Retrospective</intervention_name>
    <description>Those patients with a positive sample for ICD will be randomly selected from the microbiology database.</description>
    <arm_group_label>Retrospective group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Prospective</intervention_name>
    <description>After the routine identification of a case of DCI by the microbiology laboratory, those new cases will be included in the study.</description>
    <arm_group_label>Prospective group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Positive patients for C. difficile determined by the Microbiology Service of the General
        University Hospital Gregorio Marañón
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  For the retrospective cohort, those patients with a positive sample for ICD will be
             randomly selected from the microbiology database.

          -  For the prospective cohort: after the routine identification of a case of DCI by the
             microbiology laboratory, those new cases will be included in the study.

        Exclusion Criteria:

          -  Children under 18 years or patients with &lt;3 faeces not trained in the last 24 hours
             will not be included.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>HGU Gregorio Maranon</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Reigadas, PhD</last_name>
      <phone>+34915868453</phone>
      <email>elena.reigadas@salud.madrid.org</email>
    </contact>
    <contact_backup>
      <last_name>Emilio Bouza, MDPhD</last_name>
      <phone>+34915868453</phone>
      <email>emilio.bouza@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Elena Reigadas, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 3, 2019</study_first_submitted>
  <study_first_submitted_qc>December 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2019</study_first_posted>
  <last_update_submitted>December 17, 2019</last_update_submitted>
  <last_update_submitted_qc>December 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario Gregorio Marañon</investigator_affiliation>
    <investigator_full_name>Emilio Bouza</investigator_full_name>
    <investigator_title>Phd, MD Senior Assesor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Clostridium Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

